These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33060790)

  • 61. Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.
    Mori S; Takeuchi T; Ishii Y; Yugawa T; Kiyono T; Nishina H; Kukimoto I
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077648
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Induction of the TEAD Co-activator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.
    Gemma C; Lai CF; Singh AK; Belfiore A; Portman N; Milioli HZ; Periyasamy M; Raafat S; Nicholls AJ; Davies CM; Patel NR; Simmons GM; Fan H; Nguyen VTM; Magnani L; Rakha E; Martin LA; Lim E; Coombes RC; Pruneri G; Buluwela L; Ali S
    Cancer Res; 2024 Oct; ():. PubMed ID: 39356622
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new family of plant transcription factors displays a novel ssDNA-binding surface.
    Desveaux D; Allard J; Brisson N; Sygusch J
    Nat Struct Biol; 2002 Jul; 9(7):512-7. PubMed ID: 12080340
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The HLH domain of a zebrafish HE12 homologue can partially substitute for functions of the HLH domain of Drosophila DAUGHTERLESS.
    Wülbeck C; Fromental-Ramain C; Campos-Ortega JA
    Mech Dev; 1994 May; 46(2):73-85. PubMed ID: 7918099
    [TBL] [Abstract][Full Text] [Related]  

  • 65. RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.
    Qiao Y; Lin SJ; Chen Y; Voon DC; Zhu F; Chuang LS; Wang T; Tan P; Lee SC; Yeoh KG; Sudol M; Ito Y
    Oncogene; 2016 May; 35(20):2664-74. PubMed ID: 26364597
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of Quinolinols as Activators of TEAD-Dependent Transcription.
    Pobbati AV; Mejuch T; Chakraborty S; Karatas H; Bharath SR; Guéret SM; Goy PA; Hahne G; Pahl A; Sievers S; Guccione E; Song H; Waldmann H; Hong W
    ACS Chem Biol; 2019 Dec; 14(12):2909-2921. PubMed ID: 31742995
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Domain swapping and SMYD1 interactions with the PWWP domain of human hepatoma-derived growth factor.
    Chen LY; Huang YC; Huang ST; Hsieh YC; Guan HH; Chen NC; Chuankhayan P; Yoshimura M; Tai MH; Chen CJ
    Sci Rep; 2018 Jan; 8(1):287. PubMed ID: 29321480
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain.
    Jacquemin P; Hwang JJ; Martial JA; Dollé P; Davidson I
    J Biol Chem; 1996 Sep; 271(36):21775-85. PubMed ID: 8702974
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A protein tertiary structure mimetic modulator of the Hippo signalling pathway.
    Adihou H; Gopalakrishnan R; Förster T; Guéret SM; Gasper R; Geschwindner S; Carrillo García C; Karatas H; Pobbati AV; Vazquez-Chantada M; Davey P; Wassvik CM; Pang JKS; Soh BS; Hong W; Chiarparin E; Schade D; Plowright AT; Valeur E; Lemurell M; Grossmann TN; Waldmann H
    Nat Commun; 2020 Oct; 11(1):5425. PubMed ID: 33110077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. VGLL4 promotes osteoblast differentiation by antagonizing TEADs-inhibited Runx2 transcription.
    Suo J; Feng X; Li J; Wang J; Wang Z; Zhang L; Zou W
    Sci Adv; 2020 Oct; 6(43):. PubMed ID: 33097532
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hippo signaling: bridging the gap between cancer and neurodegenerative disorders.
    Gogia N; Chimata AV; Deshpande P; Singh A; Singh A
    Neural Regen Res; 2021 Apr; 16(4):643-652. PubMed ID: 33063715
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Willin/FRMD6 Influences Mechanical Phenotype and Neuronal Differentiation in Mammalian Cells by Regulating ERK1/2 Activity.
    Kronenberg NM; Tilston-Lunel A; Thompson FE; Chen D; Yu W; Dholakia K; Gather MC; Gunn-Moore FJ
    Front Cell Neurosci; 2020; 14():552213. PubMed ID: 33088261
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emerging role of the Hippo pathway in autophagy.
    Wang D; He J; Huang B; Liu S; Zhu H; Xu T
    Cell Death Dis; 2020 Oct; 11(10):880. PubMed ID: 33082313
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma.
    Drexler R; Küchler M; Wagner KC; Reese T; Feyerabend B; Kleine M; Oldhafer KJ
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):373-391. PubMed ID: 33098447
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 76. MiR-25-3p Serves as an Oncogenic MicroRNA by Downregulating the Expression of Merlin in Osteosarcoma.
    Rao HC; Wu ZK; Wei SD; Jiang Y; Guo QX; Wang JW; Chen CX; Yang HY
    Cancer Manag Res; 2020; 12():8989-9001. PubMed ID: 33061594
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structural and Functional Overview of TEAD4 in Cancer Biology.
    Chen M; Huang B; Zhu L; Chen K; Liu M; Zhong C
    Onco Targets Ther; 2020; 13():9865-9874. PubMed ID: 33116572
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Study of the TEAD-binding domain of the YAP protein from animal species.
    Mesrouze Y; Bokhovchuk F; Meyerhofer M; Zimmermann C; Fontana P; Erdmann D; Chène P
    Protein Sci; 2021 Feb; 30(2):339-349. PubMed ID: 33146905
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New insights in Hippo signalling alteration in human papillomavirus-related cancers.
    Olmedo-Nieva L; Muñoz-Bello JO; Manzo-Merino J; Lizano M
    Cell Signal; 2020 Dec; 76():109815. PubMed ID: 33148514
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.
    Bradley SD; Talukder AH; Lai I; Davis R; Alvarez H; Tiriac H; Zhang M; Chiu Y; Melendez B; Jackson KR; Katailiha A; Sonnemann HM; Li F; Kang Y; Qiao N; Pan BF; Lorenzi PL; Hurd M; Mittendorf EA; Peterson CB; Javle M; Bristow C; Kim M; Tuveson DA; Hawke D; Kopetz S; Wolff RA; Hwu P; Maitra A; Roszik J; Yee C; Lizée G
    Nat Commun; 2020 Oct; 11(1):5332. PubMed ID: 33087697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.